CD52 expression in non-mycotic T- and NK/T-cell lymphomas

Leukemia and Lymphoma

Volumn 48, Issue 1, 2007, Pages 117-121

  Chang, Sheng Tsung ^a   Lu, Chin Li ^a   Chuang, Shih Sung ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD52 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; T CELL LYMPHOMA; ADOLESCENT; CHILD; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, NEOPLASM; CHILD; FEMALE; GLYCOPROTEINS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34247185320     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601016167     Document Type: Article

References (17)

1. Xia, M. Q., Tone, M., Packman, L., Hale, G. and Waldmann, H. (1991) Characterization of the CAMPATH-1 (CDw52) antigen: Biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol, 21, pp. 1677-1684.
2. Hale, G., Hoang, T., Prospero, T., Watt, S. M. and Waldmann, H. (1983) Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes. Mol Biol Med, 1, pp. 305-319.
3. Wing, M. G., Moreau, T., Greenwood, J., Smith, R. M., Hale, G. and Isaacs, J. (1996) Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: Involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest, 98, pp. 19-26.
4. Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R. and Dyer, M. J. (1998) Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H. Leuk Res, 22, pp. 185-191.
5. Domagala, A. and Kurpisz, M. (2001) CD52 antigen - a review. Med Sci Monit, 7, pp. 325-331.
6. Hale, G., Dyer, M. J., Clark, M. R., Phillips, J. M., Marcus, R. and Riechmann, L. (1988) Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet, 2, pp. 1394-1399.
7. Dearden, C. E., Matutes, E. and Catovsky, D. (2002) Alemtuzumab in T-cell malignancies. Med Oncol, 19, pp. S27-S32.
8. Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A. P. and Repp, R. (2004) A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood, 103, pp. 2920-2924.
9. Salisbury, J. R., Rapson, N. T., Codd, J. D., Rogers, M. V. and Nethersell, A. B. (1994) Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas. J Clin Pathol, 47, pp. 313-317.
10. Iwamoto, N., Nagakura, S., Kawaguchi, T., Horikawa, K., Takatsuki, K. and Nakakuma, H. (1995) T-lymphoblastic lymphoma/leukemia cells negative for CD52 and CD59. Int J Hematol, 62, pp. 55-57.
11. Jaffe, E. S. and Ralfkiaer, E. (2001) Mature T-cell and NK-cell neoplasms. World Health Organization classification of tumours: Tumours of the haematopoietic and lymphoid tissues, pp. 189-235. IARC Press, Lyon
12. Lin, C. N., Chuang, S. S., Hwang, W. S. and Huang, W. T. (2004) T-cell and NK-cell lymphomas in southern Taiwan: A study of 72 cases in a single institute. Leuk Lymphoma, 45, pp. 923-928.
13. Ravandi, F., O'Brien, S., Jones, D., Lerner, S., Faderl, S. and Ferrajoli, A. (2005) T-cell prolymphocytic leukemia: A single-institution experience. Clin Lymph Myeloma, 6, pp. 234-239.
14. Osuji, N., Giudice, I Del, Matutes, E., Morilla, A., Owusu-Ankomah, K. and Morilla, R. (2005) CD52 expression in T-cell large granular lymphocyte leukemia - implications for treatment with alemtuzumab. Leuk Lymphoma, 46, pp. 723-727.
15. Chuang, S. S., Huang, W. T., Hsieh, P. P., Tseng, H. H., Campo, E. and Colomer, D. (2006) Mantle cell lymphoma in Taiwan: A clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int, 56, pp. 440-448.
16. Chuang, S. S., Lin, C. N. and Li, C. Y. (2000) Malignant lymphoma in Southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer, 89, pp. 1586-1592.
17. Liang, R. (2000) Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin. Clin Lymph Myeloma, 1, pp. 33-37.